Verena Angerer

8PUBLICATIONS
15CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesGlycoconjugatesBasic pharmacologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 31, 2026
Acute toxicity of ADB-CHMINACA - a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome.

Maren Hermanns-Clausen, Michaela Sommer, Annette Zschiesche

|Sep 08, 2022
Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids.

Michaela J Sommer, Sebastian Halter, Verena Angerer

|Feb 21, 2019
Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM).

Christina Grumann, Laura M Huppertz, Philippe Bisel

|Oct 27, 2017
Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.

Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji

Pageof 2